Cargando…

Diagnosis and treatment of non-small cell lung cancer: current advances and challenges

Detalles Bibliográficos
Autores principales:	Diebels, Ian, Van Schil, Paul E. Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264053/ https://www.ncbi.nlm.nih.gov/pubmed/35813756 http://dx.doi.org/10.21037/jtd-22-364

Ejemplares similares

Sublobar Resection for Early-Stage Lung Cancer: An Oncologically Valid Procedure?
por: Diebels, Ian, et al.
Publicado: (2023)

Operable non-small cell lung cancer: induction therapy, adjuvant therapy, or both?
por: Agrafiotis, Apostolos C., et al.
Publicado: (2023)

Current Challenges and Future Advances in Lung Cancer: Genetics, Instrumental Diagnosis and Treatment
por: Vicidomini, Giovanni
Publicado: (2023)

Immunotherapy in non-small cell lung cancer: advancements and challenges
por: Zhou, Fei, et al.
Publicado: (2021)

Non-small cell lung cancer: the new T1 categories
por: Van Schil, Paul E.
Publicado: (2017)

Advancements in next-generation sequencing for diagnosis and treatment of non-small-cell lung cancer
por: Lu, Ying-Qiang, et al.
Publicado: (2017)

Surgical treatment of early-stage non-small-cell lung cancer
por: Van Schil, Paul E., et al.
Publicado: (2013)

Lung cancer screening: the preface
por: Snoeckx, Annemiek, et al.
Publicado: (2021)

Multimodality Treatment including Surgery Related to the Type of N2 Involvement in Locally Advanced Non-Small Cell Lung Cancer
por: Allaeys, Toon, et al.
Publicado: (2022)

Neoadjuvant immunotherapy with resectable non-small cell lung cancer: recent advances and future challenges
por: Ren, Sijia, et al.
Publicado: (2020)

Biopsy and rebiopsy for non-small-cell lung cancer: current and future methods
por: Zarogoulidis, Paul, et al.
Publicado: (2019)

Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
por: Van Schil, Paul E., et al.
Publicado: (2017)

Tardive dyskinesia: understanding current challenges in diagnosis and treatment
por: Taylor, David, et al.
Publicado: (2023)

Advances in Pediatric Fracture Diagnosis and Treatment Are Numerous but Great Challenges Remain
por: van Bergen, Christiaan J. A.
Publicado: (2022)

Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence
por: Cao, Christopher, et al.
Publicado: (2020)

Lung Cancer Screening: New Perspective and Challenges in Europe
por: Van Meerbeeck, Jan P., et al.
Publicado: (2022)

Tackling the challenge of brain involvement in driver-negative non-small cell lung cancer
por: Christopoulos, Petros
Publicado: (2023)

Current Challenges and Advances in Preterm Birth
por: Farr, Alex
Publicado: (2021)

Optimal Therapy for Advanced Non-Small Cell Lung Cancer Without Driver Alterations
por: Pacheco, Jose, et al.
Publicado: (2021)

Systemic immune-inflammation index and prognosis of advanced non-small cell lung cancer
por: Alifano, Marco
Publicado: (2020)

Expert consensus on perioperative immunotherapy for locally advanced non-small cell lung cancer
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Cisplatin or carboplatin for advanced non-small cell lung cancer: does it really matter?
por: Kesireddy, Meghana, et al.
Publicado: (2021)

Is smoking history the truly best biomarker for immune checkpoint inhibitor treatment in advanced non-small cell lung cancer?
por: Pirker, Robert
Publicado: (2018)

Navigating Diagnostic and Treatment Decisions in Non‐Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach
por: Popat, Sanjay, et al.
Publicado: (2020)

The power of immunotherapy plus platinum–based chemotherapy for locally advanced or early stage non-small cell lung cancer
por: Hofman, Paul
Publicado: (2020)

The role of the surgeon in the management of oligometastatic non-small cell lung cancer: a literature review
por: Berzenji, Lawek, et al.
Publicado: (2021)

Could the clinical target volume be omitted for radiotherapy of locally advanced non-small cell lung cancer in the modern era?
por: Verma, Vivek, et al.
Publicado: (2021)

Psychosocial Care after Cancer Diagnosis: Recent Advances and Challenges
por: Tack, Laura, et al.
Publicado: (2022)

Induction treatment in operable non-small cell lung cancer: the immune oncology era unfolds
por: Walker, Paul R.
Publicado: (2023)

Local treatment of synchronous oligometastatic non-small cell lung cancer (NSCLC)—current consensus and future perspectives
por: Almeldin, Doaa Said, et al.
Publicado: (2020)

Histology Matters: Individualizing Treatment in Non-Small Cell Lung Cancer
por: Neal, Joel W.
Publicado: (2010)

Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer
por: Mamdani, Hirva, et al.
Publicado: (2017)

Treatment strategy of EGFR-mutated non-small cell lung cancer
por: Tanaka, Fumihiro, et al.
Publicado: (2022)

Tepotinib for advanced non-small-cell lung cancer with MET exon 14 skipping mutations
por: Błaszkowska, M., et al.
Publicado: (2022)

Efficacy of second-line chemotherapy after immunotherapy in advanced non-small cell lung cancer
por: Hirata, Tsuyoshi, et al.
Publicado: (2023)

Challenging scenarios in the treatment of lung cancer
por: Gelatti, Ana Caroline Zimmer, et al.
Publicado: (2020)

Innovation through Tradition: The Current Challenges in Cancer Treatment
por: Sapio, Luigi, et al.
Publicado: (2022)

Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?
por: Berzenji, Lawek, et al.
Publicado: (2023)

Current treatments for non-small cell lung cancer
por: Guo, Qianqian, et al.
Publicado: (2022)

Advances and Challenges in Diagnosis and Management of Heart Failure
por: Sullivan, Ryan D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_97co44obprtte6c5v02otfev98